Summary
Merck & Co., Inc. (MRK) filed an 8-K on January 20, 2009, primarily to disclose information related to Schering-Plough Corporation. The key disclosure is the furnishing of Schering-Plough's Frequently Asked Questions and Answers (FAQs) document, dated January 20, 2009, as an exhibit to the filing. This suggests that investors interested in the potential implications or details surrounding Schering-Plough, potentially in the context of market events or rumors at the time, would find this exhibit relevant.
Key Highlights
- 1Merck & Co., Inc. (MRK) filed an 8-K on January 20, 2009.
- 2The filing's primary purpose is Regulation FD Disclosure (Item 7.01).
- 3Merck furnished Schering-Plough Corporation's investor FAQs dated January 20, 2009, as Exhibit 99.1.
- 4The FAQs are presented as being of interest to investors.
- 5Schering-Plough makes no commitment to update the provided FAQs.
- 6Investors are advised to note the date of the information within the FAQs and other historical data.
Frequently Asked Questions
The main purpose of this 8-K filing by Merck & Co., Inc. is to disclose information related to Schering-Plough Corporation, specifically by furnishing Schering-Plough's investor-focused Frequently Asked Questions and Answers (FAQs) document dated January 20, 2009.
While not explicitly stated, this type of filing often occurs when there are significant market events, rumors, or potential business combinations involving the companies. Investors would be interested in any updates or clarifications provided by either company regarding such situations.
Schering-Plough has stated that they undertake no obligation to update the FAQs. Therefore, investors should be aware of the date of the information (January 20, 2009) and consider it historical unless otherwise indicated.
The FAQs are provided as Exhibit 99.1 to this 8-K filing. Investors would need to access the full SEC filing, including its exhibits, to read the content of the January 20, 2009, Schering-Plough FAQs.